Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study-Reference-Cited by-同舟云学术

Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study

Published:2023-09 Issue:5 Volume:61 Page:625-631
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Omori Miwako,Minegishi Yuji,Uruga Hironori,Fukuizumi Aya,Isobe Kazutoshi,Izumi Shinyu^ORCID,Koyama Ryo,Bando Masashi,Sugiyama Haruhito^ORCID,Takahashi Kazuhisa^ORCID,Gemma Akihiko,Homma Sakae^ORCID,Sugiyama Yukihiko,Kishi Kazuma^ORCID

Funder

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference25 articles.

1. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study;Hubbard;Am J Respir Crit Care Med,2000

2. Cryptogenic fibrosing alveolitis and lung cancer;Turner-Warwick;Thorax,1980

3. Clinical deterioration in patients with idiopathic pulmonary fibrosis: caused and assessment;Panos;Am J Med,1990

4. Lung cancer in patients with idiopathic pulmonary fibrosis;Park;Eur Respir J,2001

5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibody Therapies in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Two Cases of EGFR-mutated Non-small-cell Lung Cancer Treated with Erlotinib+Ramucirumab After Osimertinib-induced Lung Injury;Haigan;2024-06-20

3. Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis;Cancers;2024-04-29

4. Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives;The Journal of Medical Investigation;2024